Cantor Fitzgerald Lowers PT on Centene Corporation (CNC) to $65 From $90, Keeps an Overweight Rating

Centene Corporation (NYSE:CNC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On July 2, Cantor Fitzgerald analyst Sarah James lowered the firm’s price target on Centene Corporation (NYSE:CNC) to $65 from $90 while keeping an Overweight rating on the shares.

The analyst told investors in a research note that even when not considering the Health Insurance Exchange risk pool update, the firm saw core Q2 as holding risk for Centene Corporation (NYSE:CNC). It now believes that an even greater pressure exists on Q2 and the year.

Although Cantor Fitzgerald expressed continued likeness towards the company’s core assets, it stated that the near-term trajectory appears less certain and the path to turnaround has hit a number of products.

Centene Corporation (NYSE:CNC) is a healthcare enterprise that provides programs and services to government-sponsored healthcare programs. The company’s operations are divided into the following segments: Medicaid, Medicare, Commercial, and Other.

While we acknowledge the potential of CNC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.